F-Prime Capital (fka Fidelity Biosciences)

F-Prime Capital is a global venture capital firm that focuses on investing in healthcare and technology. With roots tracing back to Fidelity Investments, F-Prime Capital has a long history of supporting innovative companies and fostering entrepreneurship. The firm has invested in over 290 companies across various stages and sectors, with notable investments in companies like Alibaba, Moderna, and Affinia Therapeutics. F-Prime Capital's investment portfolio spans a range of industries including therapeutics, enterprise IT, fintech, and medtech. For instance, Affinia Therapeutics is working on developing transformative gene therapies, while Alibaba is a major player in the e-commerce sector. The firm has also been involved in companies like Airespace, which was acquired by Cisco, and AlphaGen Therapeutics, focusing on radiopharmaceuticals. The firm's approach includes investing in early-stage companies and supporting them through their growth phases with both capital and strategic guidance. F-Prime Capital emphasizes the importance of innovation and has been a significant player in advancing new technologies and solutions within its focus areas.